Full Professor(heuristic)

Glioma Diagnosis and Treatment · Genetics

Compare more Genetics professors.

h-index73
i10-index161
Publications580
Citations26,242

Grants

11 total · 1 active

NIH #U19CA264512

Molecular Profiling and Bioinformatics

Active
Amount
$200K–$300K
Period
2021-09-13 → 2027-08-31
PIs
1

Awarded at BECKMAN RESEARCH INSTITUTE/CITY OF HOPE

NIH #P01CA245705

Core C: Experimental Models

Amount
$500K–$600K
Period
2020-09-14 → 2025-06-30
PIs
1

Awarded at CLEVELAND CLINIC LERNER COM-CWRU

NIH #R41NS110296

Glioblastoma multiforme therapy via telomerase reverse transcriptase (hTERT) down-regulation. Molecular chaperones redirect quadruplex folding to reverse the effect of hTERT gene promoter mutations.

Amount
$400K–$500K
Period
2019-05-01 → 2022-04-30
PIs
2

Awarded at REGLAGENE, LLC

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

11 total · 1 active

NIH #U19CA264512

Molecular Profiling and Bioinformatics

Active
Amount
$200K–$300K
Period
2021-09-13 → 2027-08-31
PIs
1

Awarded at BECKMAN RESEARCH INSTITUTE/CITY OF HOPE

NIH #P01CA245705

Core C: Experimental Models

Amount
$500K–$600K
Period
2020-09-14 → 2025-06-30
PIs
1

Awarded at CLEVELAND CLINIC LERNER COM-CWRU

NIH #R41NS110296

Glioblastoma multiforme therapy via telomerase reverse transcriptase (hTERT) down-regulation. Molecular chaperones redirect quadruplex folding to reverse the effect of hTERT gene promoter mutations.

Amount
$400K–$500K
Period
2019-05-01 → 2022-04-30
PIs
2

Awarded at REGLAGENE, LLC

NIH #R01CA204136

Credentialing murine models for glioblastoma preclinical drug development

Amount
$600K–$700K
Period
2016-12-13 → 2019-11-30
PIs
3

Awarded at UNIV OF NORTH CAROLINA CHAPEL HILL

NIH #U01CA168397

Systematic Development of Novel, Druggable Cancer Targets

Amount
$800K–$900K
Period
2012-05-01 → 2017-04-30
PIs
1

Awarded at TRANSLATIONAL GENOMICS RESEARCH INST

NIH #RC2MH090878

The Southwest Comprehensive Center for Drug Discovery and Development

Amount
$2M–$3M
Period
2009-09-30 → 2011-12-31
PIs
3

Awarded at TRANSLATIONAL GENOMICS RESEARCH INST

NIH #R21NS043446

Arrested migration fosters apoptosis of glioma cells

Amount
$200K–$300K
Period
2003-09-30 → 2005-12-31
PIs
1

Awarded at TRANSLATIONAL GENOMICS RESEARCH INST

NIH #R01NS042262

Genetic Pathways of Glioma Invasion

Amount
$400K–$500K
Period
2001-08-15 → 2005-03-31
PIs
1

Awarded at TRANSLATIONAL GENOMICS RESEARCH INST

NIH #R01NS038316

ALLOGENIC GLIOMA IN IMMUNE COMPETENT DOGS

Amount
$200K–$300K
Period
1998-08-01 → 2001-04-30
PIs
1

Awarded at ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER

NIH #R01NS034437

CELLULAR AND GENETIC DETERMINANTS OF GLIOMA MIGRATION

Amount
$200K–$300K
Period
1996-04-01 → 1999-03-31
PIs
1

Awarded at ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER

NIH #R29NS027030

BRAIN TUMOR INVASION

Amount
$100K–$200K
Period
1992-07-01 → 1997-06-30
PIs
1

Awarded at ST. JOSEPH'S HOSP/MED CTR (PHOENIX)

Recent Public Signals

  1. New paper: Abstract 1270: Immunotoxin GB13 Targets GBM and H3.3K27M DIPG with the activation of Golgi-to-ER retrograde transport pathways. (Cancer Research)2026-04-03
  2. New preprint: Molecular profiling of glioblastoma-derived extracellular vesicles identifies small nucleolar RNAs as candidate liquid biomarkers for radiation- induced senescence2025-12-16
  3. New NIH award: Molecular Profiling and Bioinformatics2021-09-13

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-3382-6787

Professor Insights

Career Trajectory